Biofrontera Inc. Files 8-K on Shareholder Votes
Ticker: BFRIW · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1858685
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
Related Tickers: BFRI
TL;DR
Biofrontera Inc. filed an 8-K on June 18, 2025, detailing shareholder votes as of June 12, 2025.
AI Summary
Biofrontera Inc. filed an 8-K on June 18, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details the company's corporate structure, including common stock, preferred stock purchase rights, and warrants. The company is incorporated in Delaware and its principal executive offices are located in Woburn, Massachusetts.
Why It Matters
This filing provides transparency regarding corporate governance and shareholder decisions, which can impact investor confidence and the company's strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not indicate any immediate financial distress or significant operational changes.
Key Players & Entities
- Biofrontera Inc. (company) — Registrant
- June 12, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Woburn, Massachusetts (location) — Address of principal executive offices
FAQ
What specific matters were submitted to a vote of Biofrontera Inc. security holders?
The filing indicates that matters were submitted to a vote of security holders as of June 12, 2025, but the specific details of these matters are not provided in the excerpt.
When was the 8-K filing submitted?
The 8-K filing was submitted on June 18, 2025.
What is Biofrontera Inc.'s state of incorporation?
Biofrontera Inc. is incorporated in Delaware.
Where are Biofrontera Inc.'s principal executive offices located?
Biofrontera Inc.'s principal executive offices are located at 120 Presidential Way, Suite 330, Woburn, Massachusetts 01801.
What is the Commission File Number for Biofrontera Inc.?
The Commission File Number for Biofrontera Inc. is 001-40943.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Biofrontera Inc. (BFRIW).